Statements on this website have not been evaluated by the U.S
Significant healing 3-4 weeks
The agency cited immunogenicity concerns, saying there was limited data on the quality, stability and consistency of the compounds
Abstract Significance: The antiulcer peptide, stable gastric pentadecapeptide BPC 157 (previously employed in ulcerative colitis and multiple sclerosis trials, no reported toxicity (LD1 not achieved)), is reviewed, focusing on the particular skin wound therapy, incisional/excisional wound, deep burns, diabetic ulcers, and alkali burns, which may be generalized to the other tissues healing
General Anti-Inflammatory and Wellness Applications Anecdotal reports and rodent studies have also referenced BPC-157s ability to modulate inflammation markers
Not a drug, food, or cosmetic